Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2001–2050 of 18616
Mr. DiIorio will step down as the Company's Chief Executive Officer ("CEO"), effective May 19, 2025
As a result of the passing of Pankaj Mohan, President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Sonnet BioTherapeutics Holdings, Inc. (the “Company”), on March 31, 2025, the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer and promoted Stephen McAndrew, Ph.D., the Company’s current Chief Business Officer, to President and Chief Business Officer.
the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer
appointed Ms. Robyn Liska as Interim Chief Financial Officer of the Company effective March 31, 2025.
Eric Williams stepped down as Executive Vice President, Chief Financial Officer of the Company effective March 30, 2025.
Mark Lappe will continue in his roles as Chief Executive Officer and Chairperson of the Board of Directors, but will no longer hold the title of President.
Effective April 1, 2025, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the “Company”), will resume serving as the Company’s principal financial officer following a previously disclosed medical leave of absence that began on November 14, 2024.
On March 28, 2025, Jennifer Gravelle, Vice President, Chief Financial Officer and Treasurer of Kingstone Companies, Inc. (the “Company”), advised the Company that she will be resigning from her positions for personal reasons to pursue other opportunities.
On March 31, 2025, the Board of Directors (the “Board”) of Jack in the Box Inc. (the “Company”) appointed Mr. Lance Tucker to serve as the Company’s Chief Executive Officer and as a member of the Board, effective immediately.
On March 5, 2025, Sleep Number Corporation (the “Company”) announced that the Board of Directors unanimously appointed Linda Findley to the position of President and Chief Executive Officer and Board member, effective as of April 7, 2025.
Mr. Repp will succeed James F. Brunk, 59, who has served as Chief Accounting Officer and Corporate Controller on an interim basis since March 14, 2025, while the Company conducted a search for a permanent replacement for the Company’s prior Chief Accounting Officer. Mr. Brunk will continue serving in his current role as Chief Financial Officer of the Company.
The Company also announced that effective July 1, 2025, Lara E. Ramsey, the President of the Company and the Bank, has been appointed by the Boards of Directors of the Company and the Bank to succeed Mr. Denardo as President and Chief Executive Officer of the Company and the Bank upon his retirement.
F. Brad Denardo, the Chief Executive Officer of the Company and the Company’s wholly owned banking subsidiary, The National Bank of Blacksburg (the “Bank”), will retire from such positions effective June 30, 2025.
A. Bradley Hill, the Company’s current President and Chief Investment Officer, will assume responsibilities as the Company’s Chief Executive Officer effective April 1, 2025
H. Eric Bolton, Jr. is retiring from his position as Chief Executive Officer of Mid-America Apartment Communities, Inc. (the “Company”) effective upon the end of business on March 31, 2025
the board of directors (the “Board”) of Encore Capital Group, Inc. (the “Company”) appointed Tomas Hernanz to succeed Jonathan Clark as Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective April 1, 2025.
On March 25, 2025, Ward Morrison, President and CEO of Motto Mortgage and wemlo, subsidiaries of RE/MAX Holdings, Inc. (the “Company”), informed the Company of his intention to retire, effective June 15, 2025.
On March 26, 2025, David Gibbs, the Company’s Chief Executive Officer, informed the Board of Directors of his intention to retire in 2026.
the Board appointed Kathleen Valiasek, who currently serves as the Company’s Chief Financial Officer and President, as Chief Executive Officer of the Company, effective March 31, 2025.
the Board has appointed Jessica Buss as the Chief Executive Officer of the Company, effective immediately.
the Company and Tarak B. Mehta, the President and Chief Executive Officer of the Company, had mutually agreed that Mr. Mehta would depart from the Company, including resigning as a member of the Company’s Board of Directors (the “Board”), effective immediately.
the Board had appointed Richard G. Kyle as the interim President and Chief Executive Officer of the Company, effective immediately.
On March 25, 2025, it was agreed that the employment of Eric Hyllengren, the Chief Financial Officer and Chief Operating Officer of Atara Biotherapeutics, Inc. (the “ Company ”), would end effective March 31, 2025.
the Board appointed Steve Forte to serve as the Company’s President and Chief Executive Officer in addition to his current role as the Company’s Chief Financial Officer, effective as of the Effective Date.
On March 31, 2025, Lloyd Segal, President and Chief Executive Officer of Repare Therapeutics Inc. (the “ Company ”), notified the board of directors (the “ Board ”) of the Company of his resignation from his positions as President and Chief Executive Officer and as a member of the Board, effective April 11, 2025
On March 27, 2025, the Board terminated Michael T. Broderick from his positions as President and Chief Executive Officer of the Company effective immediately.
On March 28, 2025, the Board of Directors (“Board”) of Monro, Inc. (the “Company”) appointed Peter Fitzsimmons to serve as the President and Chief Executive Officer of the Company effective immediately.
On March 27, 2025, the Board of Directors appointed Jaime Fickett, the Company’s current Interim Chief Financial Officer, to the position of Chief Financial Officer, effective immediately.
Donald A. Moul has been appointed as TVA’s new President and Chief Executive Officer, starting April 9, 2025.
He will succeed Jeffrey J. Lyash, who is retiring from his position with TVA and will continue to serve for up to 30 days to support the transition.
On and effective as of March 28, 2025, the Board of Directors of the Company approved the appointment of Mr. Jackola as the Company’s Executive Vice President and Chief Financial Officer.
the Company's Chief Financial Officer, Sunit Patel, resigned, and Valarie Sheppard, a member of the Company's Board of Directors (the 'Board'), assumed the role of Interim Chief Financial Officer, effective March 14, 2025.
the Company's Chief Financial Officer, Sunit Patel, resigned, and Valarie Sheppard, a member of the Company's Board of Directors (the 'Board'), assumed the role of Interim Chief Financial Officer, effective March 14, 2025.
On February 25, 2025, Mr. Ernest Scheidemann informed First Choice Healthcare Solutions, Inc. (the “Company”) of his resignation as the Interim Chief Financial Officer of the Company, effective as of February 25, 2025.
Joseph Hummel resigned as Chief Executive Officer of Twin Hospitality Group Inc.
appointed Kenneth Kuick, the Company’s current Chief Financial Officer, as Interim Chief Executive Officer of the Company, effective upon Mr. Hummel’s departure.
Effective as of March 28, 2025, the Board of Directors appointed Nicolas Link (44) as the new Chief Executive Officer of the Company.
Effective March 30, 2025, the Company’s Board of Directors approved the appointment of Christopher Cooper to the position of interim Chief Executive Officer
The Board appointed Constantine Nkafu to serve as the Company’s interim CEO.
the Board appointed the Company’s Managing Director and Head of Infrastructure, Mr. Daniel De Boer, age 39, as the Company’s Interim CEO, effective April 1, 2025.
On March 28, 2025, the Board appointed Rami Hasani as the Company’s Executive Vice President, Chief Financial Officer, effective as of April 1, 2025.
Ms. Olshan will step down as the Company’s Chief Executive Officer and President ("CEO") and as a member of the Board effective as of April 11, 2025
The Board has appointed Board Chairman Adam Metz as Interim Chief Executive Officer and President ("Interim CEO") as of the Separation Date.
On March 28, 2025, Werner Cautreels notified Traws Pharma, Inc. (the Company”) of his decision to retire and resign from his role as Chief Executive Officer of the Company, effective as of the close of business on the day that the Company files its Annual Report on Form 10-K for its 2024 fiscal year
Effective as of the Termination Date, the Board appointed Iain Dukes to serve as the Company’s Interim Chief Executive Officer.
On March 27, 2025, the Board appointed Thomas Hansen as interim Chief Financial Officer
On March 24, 2025, Gerard Waldt notified the Board of Trustees (the “Board”) of T. Rowe Price OHA Select Private Credit Fund (the “Company”) of his resignation as the Company’s Chief Financial Officer
On March 24, 2025, Gerard Waldt notified the Board of Managers (the “Board”) of OHA Senior Private Lending Fund (U), LLC (the “Company”) of his resignation as the Company’s Chief Financial Officer in order to pursue other professional opportunities.
On March 27, 2025, the Board appointed Thomas Hansen as interim Chief Financial Officer of the Company effective as of the close of business on April 28, 2025.
In connection with the consummation of the Merger, James R. Scapa, Matthew Brown and Stephanie Buckner ceased to serve as the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, respectively, of the Surviving Corporation.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.